http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#head http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#assertion http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#provenance http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#publicationInfo http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#assertion http://bio2rdf.org/drugbank:DB00227 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00227_DB00238 http://bio2rdf.org/drugbank:DB00238 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00227_DB00238 http://bio2rdf.org/drugbank_resource:DB00227_DB00238 http://purl.org/dc/terms/identifier drugbank_resource:DB00227_DB00238 http://bio2rdf.org/drugbank_resource:DB00227_DB00238 http://purl.org/dc/terms/title DDI between Lovastatin and Nevirapine - The strong CYP3A4 inducer, nevirapine, may decrase the effect of lovastatin by increasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of lovastatin if nevirapine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00227_DB00238 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00227_DB00238 http://www.w3.org/2000/01/rdf-schema#label DDI between Lovastatin and Nevirapine - The strong CYP3A4 inducer, nevirapine, may decrase the effect of lovastatin by increasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of lovastatin if nevirapine is initiated, discontinued or dose changed. [drugbank_resource:DB00227_DB00238] http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#provenance http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#publicationInfo http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#signature.MCwCFDBdfuIPceWp http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#signature.MCwCFDBdfuIPceWp http://purl.org/nanopub/x/hasSignature MCwCFDBdfuIPceWpdL3xT6kYAw8ORBd1AhQ+AnuXxet/vOBTyqER7hAbJbjM3Q== http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#signature.MCwCFDBdfuIPceWp http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE http://purl.org/dc/terms/created 2018-03-30T11:12:46.116+02:00 http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#signature.MCwCFDBdfuIPceWp http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234